Chemosensitivity of drug-sensitive and drug-resistant P388 leukemia cell lines after hyperthermic treatment
Toffoli, G.; Bevilacqua, C.; Franceschin, A.; Boiocchi, M.
Journal of ChemoTherapy 1(4 Suppl): 1159-1161
1989
ISSN/ISBN: 1120-009X PMID: 16312815 Document Number: 337143
Document emailed within 1 workday
Related Documents
Goldenberg, G.J.; Wang, H.; Blair, G.W. 1986: Resistance to adriamycin: relationship of cytotoxicity to drug uptake and DNA single- and double-strand breakage in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia Cancer Research 46(6): 2978-2983Deffie, A.M.; Alam, T.; Seneviratne, C.; Beenken, S.W.; Batra, J.K.; Shea, T.C.; Henner, W.D.; Goldenberg, G.J. 1988: Multifactorial resistance to adriamycin: relationship of DNA repair, glutathione transferase activity, drug efflux, and P-glycoprotein in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia Cancer Research 48(13): 3595-3602
Tew, K.D.; Bomber, A.M.; Hoffman, S.J. 1988: Ethacrynic acid and piriprost as enhancers of cytotoxicity in drug resistant and sensitive cell lines Cancer Research 48(13): 3622-3625
Kees, U.R. 1987: Resistance to 1-beta-D-arabinofuranosylcytosine after high-dose treatment childhood lymphoblastic leukemia: isolation of a drug resistant and a sensitive cell line Cancer Research 47(12): 3088-3091
Duraj, J.; Takacsova, X.; Sedlak, J.; Sulikova, M.; Hunakova, L.; Bies, J.; Chorvath, B. 2000: PSC 833 induces apoptosis in drug-sensitive human leukemia cell line and modulates resistance to paclitaxel in its multidrug-resistant variant Anticancer Research 20(6b): 4627-4632
Meliksetian, M.B.; Berezkina, E.V.; Pavlenko, M.A.; Grinchuk, T.M. 1999: Mechanisms of drug resistance of two cell lines of human chronic promyelocytic leukemia K562, resistant to DNA topoisomerase Ii inhibitors adriamycin and etoposide Tsitologiia 41(7): 615-621
Avramis, I.A.; Kwock, R.; Avramis, V.I. 2001: Taxotere and vincristine inhibit the secretion of the angiogenesis inducing vascular endothelial growth factor (VEGF) by wild-type and drug-resistant human leukemia T-cell lines Anticancer Research 21(4a): 2281-2286
Yuan, W.; Sui, C.G.; Ma, X.; Ma, J. 2018: A novel chemo-resistant gene MSX2 discovered by establishment of two pancreatic cancer drug resistant cell lines JF305/CDDP and PANC-1/GEM Zhonghua Zhong Liu Za Zhi 40(5): 330-334
Warren, L.; Jardillier, J.C.; Ordentlich, P. 1991: Secretion of lysosomal enzymes by drug-sensitive and multiple drug-resistant cells Cancer Research 51(8): 1996-2001
Paramasivan, C.N.; Venkataraman, P.; Herbert, D. 1997: Minimal inhibitory concentrations of sulbactam/ampicillin against drug sensitive and drug resistant isolates of Mycobacterium tuberculosis Microbios 89: 360-361
Bedrnicek, J.; Vicha, A.; Jarosova, M.; Holzerova, M.; Cinatl, J.; Michaelis, M.; Cinatl, J.; Eckschlager, T. 2005: Characterization of drug-resistant neuroblastoma cell lines by comparative genomic hybridization Neoplasma 52(5): 415-419
Wallner, K.E.; DeGregorio, M.W.; Li, G.C. 1986: Hyperthermic potentiation of cis-diamminedichloroplatinum(II) cytotoxicity in Chinese hamster ovary cells resistant to the drug Cancer Research 46(12 Part 1): 6242-6245
Sulistijawati, R.Sri.; Icksan, A.Ghanie.; Lolong, D.Bisara.; Nurwidya, F. 2019: Thoracic Radiography Characteristics of Drug Sensitive Tuberculosis and Multi Drug Resistant Tuberculosis: A Study of Indonesian National Tuberculosis Prevalence Survey Acta Medica 62(1): 24-29
Rabinovich, S.A. 1976: Drug resistance of malaria parasites. 2. Clinical aspects, drug treatment and prevention of drug-resistant malaria Meditsinskaia Parazitologiia i Parazitarnye Bolezni 45(6): 731-737
de la Torre, M.; Hao, X.Y.; Larsson, R.; Nygren, P.; Tsuruo, T.; Mannervik, B.; Bergh, J. 1993: Characterization of four doxorubicin adapted human breast cancer cell lines with respect to chemotherapeutic drug sensitivity, drug resistance associated membrane proteins and glutathione transferases Anticancer Research 13(5a): 1425-1430
Calamai, P.; Carotti, S.; Guerri, A.; Mazzei, T.; Messori, L.; Mini, E.; Orioli, P.; Speroni, G.P. 1998: Cytotoxic effects of gold(III) complexes on established human tumor cell lines sensitive and resistant to cisplatin Anti-Cancer Drug Design 13(1): 67-80
Seidenfeld, J.; Sprague, W.S. 1990: Comparisons between sensitive and resistant human tumor cell lines regarding effects of polyamine depletion on chloroethylnitrosourea efficacy Cancer Research 50(3): 521-526
Stratmann, G.; Harder, S.; Hölzer, D.; Hofmann, W.K.; Ottmann, O.G.; Woodcock, B.G.; Hoffmann, W.K. 1998: Modulation of vincristine cytotoxicity by dexverapamil in sensitive and resistant HL-60 cell lines as a function of extracellular protein binding International Journal of Clinical Pharmacology and Therapeutics 36(2): 103-106
Gatto, S.; Scappini, B.; Pham, L.; Onida, F.; Milella, M.; Ball, G.; Ricci, C.; Divoky, V.; Verstovsek, S.; Kantarjian, H.M.; Keating, M.J.; Cortes-Franco, J.E.; Beran, M. 2003: The proteasome inhibitor PS-341 inhibits growth and induces apoptosis in Bcr/Abl-positive cell lines sensitive and resistant to imatinib mesylate Haematologica 88(8): 853-863
Choy, B.K.; McClarty, G.A.; Chan, A.K.; Thelander, L.; Wright, J.A. 1988: Molecular mechanisms of drug resistance involving ribonucleotide reductase: hydroxyurea resistance in a series of clonally related mouse cell lines selected in the presence of increasing drug concentrations Cancer Research 48(8): 2029-2035